Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2009
08/20/2009WO2009102824A1 Methods and compositions for detecting microorganisms
08/20/2009WO2009102789A2 Use of rxr agonists for the treatment of osteroarthritis
08/20/2009WO2009102788A2 Detecting neoplasm
08/20/2009WO2009102763A1 Microfluidic device and method of operation
08/20/2009WO2009102729A1 Association of biomarkers with patient outcome
08/20/2009WO2009102717A2 Screening methods for identifying target antifungal genes and compounds by detecting cell surface glycoproteins
08/20/2009WO2009102669A1 Method for identifying the elution time of an analyte
08/20/2009WO2009102632A2 Method for isolating cell free apoptotic or fetal nucleic acids
08/20/2009WO2009102598A1 Multiplexed analysis methods using sers-active nanoparticles
08/20/2009WO2009102474A2 Recursive estimation method and system for predicting residual bladder urine volumes
08/20/2009WO2009102470A2 Compositions and methods for use in analytical reactions
08/20/2009WO2009102453A2 System and method for quantitative assessment of biological migration behavior
08/20/2009WO2009102446A2 Fish assay for eml4 and alk fusion in lung cancer
08/20/2009WO2009102420A1 Integrated device for analyte testing, confirmation, and donor identity verification
08/20/2009WO2009102366A2 Expression of orphan gpr64 in inflammatory diseases
08/20/2009WO2009102261A1 Rbm3 as a marker for breast cancer prognosis
08/20/2009WO2009102092A1 Method of detecting bioproducts using localized surface plasmon resonance sensor of gold nanoparticles
08/20/2009WO2009102080A1 Vector for screening antibody
08/20/2009WO2009101968A1 Anti-adam-15 antibodies and utilization of the same
08/20/2009WO2009101942A1 Screening method
08/20/2009WO2009101807A1 Peptide, use of the peptide, method for production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support
08/20/2009WO2009101700A1 Bioassay method for yokkansan
08/20/2009WO2009101538A2 Quality control for bilirubinometers
08/20/2009WO2009101395A1 Particle separation apparatus and methods
08/20/2009WO2009101392A1 System and method for measuring properties of liquid in multiphase mixtures using two open ended coaxial probes with different sensitivity depths
08/20/2009WO2009101383A1 Mutant proteins and methods for selecting them
08/20/2009WO2009101291A2 System for monitoring a gas storage formation
08/20/2009WO2009101265A1 Method and apparatus for intensifying ore prospecting
08/20/2009WO2009101242A1 Method for predicting a future property
08/20/2009WO2009101181A2 Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
08/20/2009WO2009101118A1 Apparatus and method for detecting triacetone triperoxide
08/20/2009WO2009101048A1 Apparatus and method for the detection of liquids or substances from liquids, and use of said apparatus
08/20/2009WO2009101037A1 Means and methods for determining the atherosclerosis load using the biomarker plgf
08/20/2009WO2009100991A1 Electroluminescent metal complexes with dibenzo[f,h]quinoxalines
08/20/2009WO2009100953A2 Diagnostic method
08/20/2009WO2009100907A1 Means and methods for assessing the risk of patients presenting to emergency departments based on very low concentrations of troponin i or t or using a combination of markers
08/20/2009WO2009100896A1 Methods for identification of an antibody or a target
08/20/2009WO2009100797A1 Device for fixing an electronic component to a carrier by means of a conductive refractory metal-glass paste
08/20/2009WO2009100760A1 Cellular screening assay for modulators of mevalonate pathway
08/20/2009WO2009100731A1 An effective new drug target for the treatment of tuberculosis
08/20/2009WO2009100516A1 Cell culture and cell assays using digital microfluidics
08/20/2009WO2009082242A3 Optical analyte detection incorporating a micromirror device
08/20/2009WO2009081309A3 A magnetic sensor device
08/20/2009WO2009078806A3 Skeletal muscle proteome, muscle function and physical performance
08/20/2009WO2009076129A3 Virtual engine oil quality sensor
08/20/2009WO2009074331A3 Early and differential diagnosis test for alzheimer's disease
08/20/2009WO2009074276A3 Marker panel for colorectal cancer
08/20/2009WO2009072812A3 Method for selective labeling and detection of target nucleic acids using immobilized peptide nucleic acid probes
08/20/2009WO2009071852A3 Functionalised biochips for spr-ms coupling
08/20/2009WO2009066990A3 Apparatus for soil nutrient analysis
08/20/2009WO2009065596A3 Use of mnk inhibitors for the treatment of alzheimer's disease
08/20/2009WO2009062497A3 Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay
08/20/2009WO2009061935A3 Methods of identifying safe nmda receptor antagonists
08/20/2009WO2009058902A3 Methods and devices for analyte detection
08/20/2009WO2009044370A3 Reversed flow-through deviceand method for rapid analysis of target analytes
08/20/2009WO2009043565A8 Method for identifying the interaction partner of an active agent
08/20/2009WO2009036768A3 Diagnosing potential weight gain in a subject
08/20/2009WO2009024922A3 Method of directing magnetic or magnetisable objects to prepare bio-sensor device
08/20/2009WO2009023358A3 Compositions for use in identification of strains of hepatitis c virus
08/20/2009WO2009012156A3 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders
08/20/2009WO2009005869A3 Biological detection system and method
08/20/2009WO2009004484A3 Trim24 (tifla) as p53 modulator and cancer target
08/20/2009WO2006088976A3 Fiber-optic biosensor and biosensing methods
08/20/2009US20090210950 Methods for screening for agents that affect development
08/20/2009US20090210949 Method of ameliorating symptom caused by mood disturbance
08/20/2009US20090209904 Diagnostic Radio Frequency Identification Sensors And Applications Thereof
08/20/2009US20090209867 Method for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
08/20/2009US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same
08/20/2009US20090209652 Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy
08/20/2009US20090209580 Antitumor agent for thyroid cancer
08/20/2009US20090209551 Essential tremor diagnostic and treatment
08/20/2009US20090209526 Inhibitors of protein aggregation
08/20/2009US20090209525 Enabling methods to identify allosteric modulators of receptor activity
08/20/2009US20090209474 Novel uses for drugs targeting glutamine synthetase
08/20/2009US20090209470 T24 antigen for immunodiagnosis of taenia solium cysticercosis
08/20/2009US20090209465 MCT1 Transporters Expressed in Blood Brain Barrier Cells
08/20/2009US20090209462 Regulation of function of angiopoietin
08/20/2009US20090209450 MicroRNA Fingerprints During Human Megakaryocytopoiesis
08/20/2009US20090209435 Methods of screening for TRPM4b modulators
08/20/2009US20090209431 Non-Invasive in Vitro Method to Detect Transitional Cell Carcinoma of the Bladder
08/20/2009US20090209049 Use of metal complexes
08/20/2009US20090209048 Luminescence Biotin-Transition Metal Complex Conjugate, and Method of Amplifying Signal Using the Same
08/20/2009US20090209047 Biomarkers and assays for myocardial infarction
08/20/2009US20090209046 Neutral Pharmaceuticals
08/20/2009US20090209045 Screening assay
08/20/2009US20090209041 Peptides and methods for inhibiting amyloid formation
08/20/2009US20090209034 Tumour rejection antigens
08/20/2009US20090208997 GPR18 as a Biomaker for TH1 Mediated Immune Response
08/20/2009US20090208990 Human protein acyl transferases and methods of uses therefor
08/20/2009US20090208989 Fluorescence Spectropscopy In Absorbing Media
08/20/2009US20090208988 using a hemostasis analyzer is to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters
08/20/2009US20090208987 Method and Composition for Stabilizing Liquid Reagents
08/20/2009US20090208986 Method and kit for diagnosing acute myocardial infarction
08/20/2009US20090208985 Method Of Evaluating Degree Of Skin Sensitivity Using Squamous Cell Carcinoma Antigen As An Indicator Thereof
08/20/2009US20090208984 DETECTION OF FOOD SPECIFIC HUMAN IgG4 ANTIBODIES
08/20/2009US20090208983 Diagnose device for measuring the ratio of proteins with similar structure
08/20/2009US20090208982 Assay method for human orotate phosphoribosyltransferase protein
08/20/2009US20090208981 Method for Analysis of Interaction Between Small Molecules and Cells and Apparatus thereof
08/20/2009US20090208980 Method of identifying cancer biomarkers and cancer progression
08/20/2009US20090208979 Method for identifying antipsychotic drug candidates
1 ... 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 ... 3937